Trifluridine/tipiracil outcomes in third- or later lines versus placebo in metastatic gastric cancer treatment: An exploratory subgroup analyses from the TAGS study Meeting Abstract
| Authors: | Tabernero, J.; Shitara, K.; Zaanan, A.; Doi, T.; Lorenzen, S.; Van Cutsem, E.; Fornaro, L.; Catenacci, D. V. T.; Fougeray, R.; Vera, S. R. M.; Azcue, P.; Arkenau, H. T.; Alsina, M.; Ilson, D. H. |
| Abstract Title: | Trifluridine/tipiracil outcomes in third- or later lines versus placebo in metastatic gastric cancer treatment: An exploratory subgroup analyses from the TAGS study |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800261 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.229 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 229 -- Source: Wos |
